Non-Viral Gene Therapy 2011
DOI: 10.5772/18831
|View full text |Cite
|
Sign up to set email alerts
|

Chitosan and Its Modifications: Are They Possible Vehicles for Gene Therapy?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2019
2019
2019
2019

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…and Rabea (2017), the transfection efficiency of chitosan depends on the degree of acetylation, molecular weight, pH of the transfecting media, cell type, and the charge ratio of the luciferase plasmid to chitosan. Limitations in the use of chitosan for non-viral gene therapy were previously reported by Kedjarune-Leggat and Leggat (2011). Most of the results on gene therapy using chitosan were obtained from experiments in vitro, and further research is needed in vivo.…”
Section: Medicinementioning
confidence: 99%
“…and Rabea (2017), the transfection efficiency of chitosan depends on the degree of acetylation, molecular weight, pH of the transfecting media, cell type, and the charge ratio of the luciferase plasmid to chitosan. Limitations in the use of chitosan for non-viral gene therapy were previously reported by Kedjarune-Leggat and Leggat (2011). Most of the results on gene therapy using chitosan were obtained from experiments in vitro, and further research is needed in vivo.…”
Section: Medicinementioning
confidence: 99%
“…Genetic materials such as deoxyribonucleic acids and ribonucleic acid are used in gene therapy as pharmaceutical agents to treat various diseases (Lee 2007;Dash et al 2011;Kedjarune-Leggat and Leggat 2011;Choi et al 2016;Badawy and Rabea 2017). However, the use of genetic materials is limited due to rapid degradation by nuclease, large size, poor cellular uptake, high anionic charge density, and also non-specificity.…”
Section: Medicinementioning
confidence: 99%
“…As recently reviewed by Badawy and Rabea (2017), the transfection efficiency of chitosan depends on the degree of acetylation, molecular weight, pH of the transfecting media, cell type, and the charge ratio between the luciferase plasmid to chitosan. Limitations in the use of chitosan for non-viral gene therapy were previously reported by Kedjarune-Leggat and Leggat (2011). Most of the results on gene therapy using chitosan were obtained from experiments in vitro and further research is needed in vivo.…”
Section: Medicinementioning
confidence: 99%